Paloma Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,665
| Closed | -$406K | – | 932 |
|
|
2024
Q3 | $406K | Sell |
1,665
-7,731
| -82% | -$1.73M | 0.01% | 692 |
|
|
2024
Q2 | $1.8M | Buy |
+9,396
| New | +$1.91M | 0.05% | 369 |
|
|
2022
Q2 | – | Sell |
-4,395
| Closed | -$1.07M | – | 1652 |
|
|
2022
Q1 | $1.07M | Sell |
4,395
-11,578
| -72% | -$2.8M | 0.03% | 417 |
|
|
2021
Q4 | $4.16M | Buy |
+15,973
| New | +$4.14M | 0.06% | 259 |
|
|
2021
Q3 | – | Sell |
-1,402
| Closed | -$345K | – | 1746 |
|
|
2021
Q2 | $345K | Sell |
1,402
-27,801
| -95% | -$5.84M | 0.01% | 1232 |
|
|
2021
Q1 | $5.67M | Buy |
29,203
+25,509
| +691% | +$5.12M | 0.12% | 135 |
|
|
2020
Q4 | $785K | Sell |
3,694
-9,035
| -71% | -$1.8M | 0.02% | 682 |
|
|
2020
Q3 | $2.18M | Buy |
+12,729
| New | +$2.35M | 0.06% | 361 |
|
|
2020
Q2 | – | Sell |
-3,323
| Closed | -$489K | – | 2209 |
|
|
2020
Q1 | $489K | Buy |
+3,323
| New | +$529K | 0.03% | 510 |
|
|
2019
Q4 | – | Sell |
-9,282
| Closed | -$1.25M | – | 2441 |
|
|
2019
Q3 | $1.25M | Buy |
+9,282
| New | +$1.22M | 0.03% | 626 |
|
|
2019
Q1 | – | Sell |
-17,460
| Closed | -$1.99M | – | 1894 |
|
|
2018
Q4 | $1.99M | Buy |
17,460
+14,872
| +575% | +$1.59M | 0.06% | 247 |
|
|
2018
Q3 | $298K | Sell |
2,588
-18,166
| -88% | -$1.99M | 0.01% | 1234 |
|
|
2018
Q2 | $2.15M | Buy |
+20,754
| New | +$2.1M | 0.04% | 421 |
|
|
2018
Q1 | – | Sell |
-19,573
| Closed | -$1.85M | – | 2220 |
|
|
2017
Q4 | $1.66M | Sell |
19,573
-13,735
| -41% | -$1.13M | 0.02% | 764 |
|
|
2017
Q3 | $2.56M | Buy |
+33,308
| New | +$2.55M | 0.04% | 589 |
|
|
2017
Q2 | – | Sell |
-7,276
| Closed | -$523K | – | 2391 |
|
|
2017
Q1 | $523K | Buy |
+7,276
| New | +$503K | 0.01% | 1565 |
|
|
2016
Q4 | – | Sell |
-32,739
| Closed | -$2.12M | – | 2118 |
|
|
2016
Q3 | $2.12M | Buy |
+32,739
| New | +$2.18M | 0.03% | 512 |
|
|
2016
Q2 | – | Sell |
-28,015
| Closed | -$1.62M | – | 2313 |
|
|
2016
Q1 | $1.62M | Sell |
28,015
-2,342
| -8% | -$133K | 0.03% | 584 |
|
|
2015
Q4 | $1.63M | Buy |
+30,357
| New | +$1.71M | 0.04% | 448 |
|
|
2015
Q3 | – | Sell |
-5,156
| Closed | -$291K | – | 1869 |
|
|
2015
Q2 | $291K | Sell |
5,156
-26,609
| -84% | -$1.68M | 0.01% | 1347 |
|
|
2015
Q1 | $2.28M | Sell |
31,765
-8,040
| -20% | -$522K | 0.06% | 264 |
|
|
2014
Q4 | $2.23M | Buy |
+39,805
| New | +$2.08M | 0.1% | 226 |
|
|
2014
Q3 | – | Sell |
-34,521
| Closed | -$1.75M | – | 1257 |
|
|
2014
Q2 | $1.75M | Buy |
+34,521
| New | +$1.71M | 0.07% | 252 |
|
|
2013
Q4 | – | Sell |
-4,920
| Closed | -$260K | – | 1171 |
|
|
2013
Q3 | $260K | Sell |
4,920
-3,166
| -39% | -$154K | 0.01% | 695 |
|
|
2013
Q2 | $365K | Buy |
+8,086
| New | +$384K | 0.02% | 589 |
|
Other funds holding RMD
Paloma Partners's RMD Position: Q4 2024 in Review
Paloma Partners sold out of ResMed (RMD) in Q4 2024, closing a stake of 1,665 shares — an estimated $406K sold.
Paloma Partners first reported a position in RMD in Q2 2013 and held it in 25 quarters. The position peaked at $5.67M in Q1 2021. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.
- Paloma Partners reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
- Paloma Partners sold 1,665 ResMed shares in Q4 2024, an estimated $406K.
- Paloma Partners first reported a position in ResMed in Q2 2013 and held it in 25 quarters.
- Paloma Partners's ResMed position peaked at $5.67M in Q1 2021.
- 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.
Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.